393 related articles for article (PubMed ID: 34693748)
1. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
[TBL] [Abstract][Full Text] [Related]
2. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
[TBL] [Abstract][Full Text] [Related]
3. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
Kennedy-Shaffer L; Hughes MD
Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
[TBL] [Abstract][Full Text] [Related]
4. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
Westgate PM
Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
[TBL] [Abstract][Full Text] [Related]
5. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
Moerbeek M
Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
[TBL] [Abstract][Full Text] [Related]
6. Determining the sample size for a cluster-randomised trial using knowledge elicitation: Bayesian hierarchical modelling of the intracluster correlation coefficient.
Tishkovskaya SV; Sutton CJ; Thomas LH; Watkins CL
Clin Trials; 2023 Jun; 20(3):293-306. PubMed ID: 37036110
[TBL] [Abstract][Full Text] [Related]
7. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
Braschel MC; Svec I; Darlington GA; Donner A
Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical Bayesian modeling of heterogeneous outcome variance in cluster randomized trials.
Tong G; Tong J; Jiang Y; Esserman D; Harhay MO; Warren JL
Clin Trials; 2024 Jan; ():17407745231222018. PubMed ID: 38197388
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for the analysis of individually randomised controlled trials with clustering in one arm - a case of continuous outcomes.
Flight L; Allison A; Dimairo M; Lee E; Mandefield L; Walters SJ
BMC Med Res Methodol; 2016 Nov; 16(1):165. PubMed ID: 27899073
[TBL] [Abstract][Full Text] [Related]
10. swdpwr: A SAS macro and an R package for power calculations in stepped wedge cluster randomized trials.
Chen J; Zhou X; Li F; Spiegelman D
Comput Methods Programs Biomed; 2022 Jan; 213():106522. PubMed ID: 34818620
[TBL] [Abstract][Full Text] [Related]
11. Improving efficiency in the stepped-wedge trial design via Bayesian modeling with an informative prior for the time effects.
Zhan D; Ouyang Y; Xu L; Wong H
Clin Trials; 2021 Jun; 18(3):295-302. PubMed ID: 33813906
[TBL] [Abstract][Full Text] [Related]
12. Bayesian evaluation of informative hypotheses in cluster-randomized trials.
Moerbeek M
Behav Res Methods; 2019 Feb; 51(1):126-137. PubMed ID: 30350025
[TBL] [Abstract][Full Text] [Related]
13. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
Candel MJ; van Breukelen GJ
Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
[TBL] [Abstract][Full Text] [Related]
14. Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations.
Wang X; Turner EL; Li F
Stat Med; 2024 Jan; 43(2):358-378. PubMed ID: 38009329
[TBL] [Abstract][Full Text] [Related]
15. Estimating Standardized Effect Sizes for Two- and Three-Level Partially Nested Data.
Lai MH; Kwok OM
Multivariate Behav Res; 2016; 51(6):740-756. PubMed ID: 27802077
[TBL] [Abstract][Full Text] [Related]
16. Power considerations for generalized estimating equations analyses of four-level cluster randomized trials.
Wang X; Turner EL; Preisser JS; Li F
Biom J; 2022 Apr; 64(4):663-680. PubMed ID: 34897793
[TBL] [Abstract][Full Text] [Related]
17. Designing multicenter individually randomized group treatment trials.
Tong G; Tong J; Li F
Biom J; 2024 Jan; 66(1):e2200307. PubMed ID: 37768850
[TBL] [Abstract][Full Text] [Related]
18. Intraclass correlation coefficients for cluster randomized trials in primary care: the cholesterol education and research trial (CEART).
Parker DR; Evangelou E; Eaton CB
Contemp Clin Trials; 2005 Apr; 26(2):260-7. PubMed ID: 15837446
[TBL] [Abstract][Full Text] [Related]
19. Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.
Tong G; Taljaard M; Li F
Stat Med; 2023 Aug; 42(19):3392-3412. PubMed ID: 37316956
[TBL] [Abstract][Full Text] [Related]
20. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
Moerbeek M
Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
